2016
DOI: 10.1111/1440-1681.12531
|View full text |Cite
|
Sign up to set email alerts
|

PREDICT score and CYP2C19 polymorphism independently predict lack of efficacy of clopidogrel in cardiology patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Tel: +420 495067295; Fax: +420 495067170; E-mail: mladenkap@faf.cuni.cz ment with both types of substances is problematic: in around 5-45% of ASA users there is a treatment failure and/or resistance [1] and antagonists to ADP receptors (ticlopidin and clopidogrel) are associated with drug interactions [2,3]. The latest representatives of the latter (ticagrelor, elinogrel, cangrelor) are not prodrugs and hence have a smaller potential for such interactions but their use in clinical practise is relatively recent and the side-effects of long-term treatment have not yet been established.…”
Section: Introductionmentioning
confidence: 99%
“…Tel: +420 495067295; Fax: +420 495067170; E-mail: mladenkap@faf.cuni.cz ment with both types of substances is problematic: in around 5-45% of ASA users there is a treatment failure and/or resistance [1] and antagonists to ADP receptors (ticlopidin and clopidogrel) are associated with drug interactions [2,3]. The latest representatives of the latter (ticagrelor, elinogrel, cangrelor) are not prodrugs and hence have a smaller potential for such interactions but their use in clinical practise is relatively recent and the side-effects of long-term treatment have not yet been established.…”
Section: Introductionmentioning
confidence: 99%